Sixty thousand people in the United States are supposed to die this year because they did not receive a kidney allograft. Worldwide, the number could exceed 1 million; In India itself the number of people developing end stage renal disease each year is about 100,000. But with such prohibitive policies, can we prevent the development of a black market worldwide? Numerous reports from all over the world disagree.